Clinical Trial Update: Short-Term Application of Tocilizumab Following Myocardial Infarction [NA]

View source ↗

Summary

Clinical trial update indicates short-term use of tocilizumab after myocardial infarction completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Keesler Air Force Base Medical Center | Conditions: Myocardial Infarction | NA | Status: COMPLETED | Results posted: 2017-11-17